Epstein-Barr virus latency switch in human B-cells: A physico-chemical model

BMC Systems Biology

Volumn 1, Issue , 2007, Pages

  Werner, Maria ^a   Ernberg, Ingemar ^b   Zou, Jiezhi ^b   Almqvist, Jenny ^b   Aurell, Erik ^a  

^a ALBANOVA UNIVERSITY CENTER   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN HERPESVIRUS 4;

EBV ENCODED NUCLEAR ANTIGEN 1; EBV-ENCODED NUCLEAR ANTIGEN 1; EPSTEIN BARR VIRUS ANTIGEN; OCTAMER TRANSCRIPTION FACTOR 2; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; BIOLOGICAL MODEL; CELL CULTURE; CHEMICAL MODEL; CHEMISTRY; COMPUTER SIMULATION; EPSTEIN BARR VIRUS; GENETICS; HUMAN; PHYSIOLOGY; PROMOTER REGION; VIROLOGY; VIRUS LATENCY;

B-LYMPHOCYTES; CELLS, CULTURED; COMPUTER SIMULATION; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; HUMANS; MODELS, CHEMICAL; MODELS, GENETIC; OCTAMER TRANSCRIPTION FACTOR-2; PROMOTER REGIONS (GENETICS); VIRUS LATENCY;

EID: 37749007113     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-1-40     Document Type: Article

References (48)

1. Young LS Rickinson AB: Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004, 4:757-768. 10.1038/nrc1452 15510157
2. Almqvist J: Epstein-Barr virus nuclear antigen 1, Oct & Groucho/TLE in control of promoter regulation. PhD thesis, Karolinska Institutet 2005
3. Amon W Farrell PJ: Reactivation of Epstein-Barr virus from latency. Reviews in Medical Virology 2005, 15:149-156. 10.1002/rmv.456 15546128
4. LeAght ER Sugden B: EBNA-1: a protein pivotal to latent infection bt Epsein-barr virus. Reviews in Medical Virology 2000, 10:83-100. 10.1002/ (SICI)1099-1654(200003/04)10:2<83::AID-RMV262<3.0.CO;2-T 10713596
5. Schaefer BC Woisetschlager M Strominger JL Speck SH: Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitts lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes. Proc Natl Acad Sci 1991, 88:6550-6554. 52124 1713681 10.1073/pnas.88.15.6550
6. Schaefer BC Strominger JL Speck SH: Host-cell-determined methylation of specific Epstein-Barr virus promoter regulates the choice between distinct viral latency programs. Molecular and Cellular Biology 1997, 17:364-377.
7. Zetterberg H Stenglein M Jansson A Ricksten A Rymo L: Relative levels of EBNA1 gene transcripts from the C/W, F and Q promoters in Epstein-Barr virus-transformed lymphoid cells in latent and lytic stages of infection. Journal of General Virology 1999, 80:457-465. 10073708
8. Tsai CN Liu ST Chang YS: Identification of a novel promoter located within the BamHIQ region of the Epstein-barr virus genome for the EBNA 1 gene. DNA and Cell Biology 1995, 14: 767-776.
9. Nonkwelo C Ruf IK Sample J: The Epstein-Barr virus EBNA-1 promoter Qp requires an intitator-like element. Journal of Virology 1997, 71:354-361. 191058 8985357
10. Bodescot M Perricaudet M Farrell PJ: A promoter for the highly spliced EBNA family of RNAs of Epstein-Barr virus. Journal of Virology 1987, 61:3424-3430. 255938 2822952
11. Almqvist J Zou J Linderson Y Borestrom C Altiok E Zetterberg H Rymo L Petterson S Ernberg I: Functional interaction of Oct transcription factors with the family of repeats in Epstein-Barr virus oriP. Journal of General Virology 2005, 86:1261-1267. 10.1099/vir.0.80620-0 15831936
12. Reisman D Sugden B: Trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1. Molecular and Cellular Biology 1986, 6:3838-3846.
13. Sugden B Warren N: A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA repliction during latent infection. Journal of Virology 1999, 73:2644-2649.
14. Wysokenski DA Yates JL: Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus. Journal of Virology 1989, 63:2657-2666. 250751 2542579
15. Zetterberg H Borestrom C Nilsson T Rymo L: Multiple EBNA1-binding sites within oriPI are required for EBNA1-dependent transactivation of the Epstein-Barr virus C promoter. International Journal of Oncolocy 2004, 25:693-696.
16. Malin S Linderson Y Almqvist J Ernberg I Tallone T Petterson S: DNA-dependent conversion of Oct-1 and Oct-2 into transcriptional repressors by Groucho/TLE. Nucleic Acids Research 2005, 33:4618-4625. 1187819 16103132 10.1093/nar/gki744
17. Sung NS Kenney S Gutch D Pagano JS: EBNA-2 transcativates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus. Journal of Virology 1991, 65:2164-2169. 240563 1850003
18. Ling PD Rawlins DR Hayward SD: The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein. Proc Natl Acad Sci 1993, 90:9237-9241. 47542 8415684 10.1073/ pnas.90.20.9237
19. Kupfer SR Summers WC: Identification of a Glucocorticoid-responsive element in Epstein-Barr virus. Journal of Virology 1990, 64:1984-1990. 249352 2157866
20. Nilsson T Zetterberg H Wang YC Rymo L: Promoter-proximal regulatory elements involved in oriP-EBNA1-independent and -dependent activation of the Epstein-Barr virus C promoter in B-lymphoid cell lines. Journal of Virology 2001, 75:5796-5811. 114295 11390581 10.1128/ JVI.75.13.5796-5811.2001
21. Puglielli MT Woisetschlaeger M Speck SH: OriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines. Journal of Virology 1996, 70:5758-5768. 190589 8709191
22. Roder K Wolf S Larkin K Schweizer M: Interaction between the two ubiquitously expressed transcription factors NF-Y and Sp1. Gene 1999, 234:61-69. 10.1016/S0378-1119(99)00180-8 10393239
23. Guerra RF Imperadori L Mantovani R Dunlap DD Finzi L: DNA compaction by the nuclear factor Y (NF-Y). Biophys J 2007, 93(1):176-182. 10.1529/ biophysj.106.099929 17434933
24. Mantovani R: Review: The molecular biology of the CCAAt-binding factor NF-y. gene 1999, 239:15-27. 10.1016/S0378-1119(99)00368-6 10571030
25. Schaefer BC Strominger JL Speck SH: Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. Proc Natl Acad Sci 1995, 92:10565-10569. 40652 7479841 10.1073/pnas.92.23.10565
26. Schaefer BC Paulson E Strominger JL Speck SH: Constitutive activation of Epstein-Barr virus (EBV) nuclear antigen 1 gene transcription by IRF1 and IRF2 during restricted EBV latency. Molecular and Cellular Biology 1997, 17:873-886.
27. Sung NS Wilson J Davenport M Sista ND Pagano JS: Reciprocal regulation of the Epstein-Barr virus BamHI-F promoter by EBNA-1 and an E2F transcription factor. Molecular and Cellular Biology 1994, 14:7144-7152.
28. Ruf IK Sample J: Repression of Epstein-Barr virus EBNA-1 gene transcription by pRb during restricted latency. Journal of Virology 1999, 73:7943-7951. 112808 10482541
29. Sample J Henson EB Sample C: The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated. J Virol 1992, 66:4654-4661. 241289 1321268
30. Shea M Ackers G: The OR control system of bacteriophage lambda. A physical-chemical model for gene regulation. J Mol Biol 1985, 181:211-230. 10.1016/0022-2836(85)90086-5 3157005
31. Bintu L Buchler NE Garcia HG Gerland U Hwa T Kondev J Kuhlman T Phillips R: Transcriptional regulation by the Mumbers: models. Curr Opin Genet Dev 2005, 15:116-124. 10.1016/j.gde.2005.02.007 15797194
32. Reinitz J Vaisnys JR; Theoretical and experimental analysis of the phage lambda genetic switch implies missing levels of co-operativity. Journal of Theoretical Biology 1990, 145:295-318. 2146446
33. Aurell E Brown S Johanson J Sneppen K: Stability puzzles in phage lambda. Physical Review E 2002, 65:051914-051914. 10.1103/ PhysRevE.65.051914
34. Salamon D Takacs M Ujvari D Uhlig J Wolf H Minarovits J Niller HH: Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p pf Epstein-Barr virus. J Virol 2001, 75:2584-2596. 115881 11222681 10.1128/JVI.75.6.2584-2596.2001
35. Chau CM Zhang XY McMahon SB Lieberman PM: Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF. J Virol 2006, 80:5723-5732. 1472585 16731911 10.1128/JVI.00025-06
36. Brantjes H Roose J van De Wetering M Clevers H: All Tcf HMG box transcription factors interact with Groucho-related co-repressors. Nucleic Acids Res 2001, 29:1410-1419. 31284 11266540 10.1093/nar/ 29.7.1410
37. Pokrovskaja K Ehlin-Henriksson B Kiss C Challa A Gordon J Gogolak P Klein G Szekely L: CD40 ligation downregulates EBNA-2 and LMP-1 expression in EBV-transformed lymphoblastoid cell lines. Int J Cancer 2002, 99:705-712. 10.1002/ijc.10417 12115504
38. Hong M Murai Y Kutsuna T Takahashi H Nomoto K ans Shin Ishizawa CMC Zhao QL Ogawa R Harmon BV Tsuneyama K Takano Y: Suppression of Epstein-barr nuclear antigen 1 (EBNA1) by RNA interference inhibits proliferation of EBV-positive Burkitt's lymphoma cells. Journal of Cancer Research and Clinical Oncology 2006, 132:1-8. 10.1007/s00432-005-0036-x
39. Ambinder RF Shah WA Rawlins DR Hayward GS Hayward SD: Definition of the sequence requirements for binding of the EBNA-1 protein to its palindromic target sites in Epstein-Barr virus DNA. Journal of Virology 1990, 64:2369-2379. 249398 2157891
40. Frappier L O'Donnell M: Overproduction, purification and characterization of EBNA1, the origin binding protein of Epstein-Barr virus. The Journal of Biological Chemistry 1991, 266:7819-1826. 1850421
41. Shah PC Bertolino E Singh H: Using altered specificity Oct-1 and Oct-2 mutants to analyze the regulation of immunoglobulin gene transcription. The EMBO Journal 1997, 16:7105-7117. 1170312 9384588 10.1093/emboj/ 16.23.7105
42. Verrijzer C Alkema M van Weperen W Leeuwen HV Strating M van der Vliet P: The DNA binding specificity of the bipartite POU domain and its subdomains. EMBO J 1992, 11:499-5003. 556977 1361172
43. Sternas L Middleton T Sugden B: The average number of molecules of Epstein-Barr nuclear antigen 1 per cell does not correlate with the average number of Epstein-Barr virus (EBV) DNA molecules per cell among different clones of EBV-immortalized cells. J Virol 1990, 64:2407-2410. 249405 2157896
44. Davenport MG Pagano JS: Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr virus type I latency. Journal of Virology 1999, 73:3154-3161. 104077 10074167
45. Levitskaya J Sharipo A Leonchiks A Ciechanover A Masucci MG: Inhibition of ubiquitin/proteasome-dependent protein degradation by hte Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc Natl Acad Sci USA 1997, 94:12616-12621. 25057 9356498 10.1073/pnas.94.23.12616
46. Woo KB Funkhouser WK Sullivan C Alabaster O: Analysis of the proliferation kinetics of Burkitt's lymphoma cells. Cell Tissue Kinteics 1980, 13:591-604.
47. Daikoku T Kudoh A Fujita M Sugaya Y Isomura H Tsurumi T: In vivo dynamics of EBNA-oriP interaction during latent and lytic replication of Epstein-Barr virus. Journal of Biological Chemistry 2004, 279:54817-54825. 10.1074/jbc.M405911200 15498777
48. Abbas AK Lichtman AH Pober JS: Cellular and molecular immunology. Philadelphia: W.B. Saunders Company 2000.